Accrual Culture: Top Points for Site Selection - Timelines
The GOG Foundation, Inc. would like to thank our commercial supporters for their support of the GOG GYN-LIVE Podcast:Corcept Therapeutics, GSK, Pfizer Oncology, Eli Lilly, Genmab, and Verastem ★ Su...
2 Apr 20min
Accrual Culture: Top Points for Site Selection - Responsiveness
6 Mar 17min
GOG-3101 | TroFuse-20 Clinical Trial Update
In this episode, we dive into GOG‑3101 TroFuse‑20—a Phase 3, randomized, active‑controlled, open‑label, multicenter study evaluating MK‑2870 monotherapy versus Treatment of Physician’s Choice as secon...
5 Mar 13min
The GOG Highlight Reel - January 2026
The GOG Foundation, Inc. and GOG Partners are thrilled to present the “The GOG Highlight Reel”, an ongoing Education Series that showcases clinical trials and other newsworthy education, from major me...
20 Feb 2h 15min
KEYNOTE-B96 FDA APPROVAL REVIEW
16 Feb 19min
Accrual Culture: Top Points for Site Selection - Feasibility
5 Feb 15min
Accrual Culture: Top Points for Site Selection - Enrollement
The GOG Partners Leadership presents the “Accrual Culture: An Education Series on How to Build a Successful Clinical Trial Network.” The purpose of this on-demand education series is to share key comp...
30 Jan 18min
2026 Cervical Cancer Awareness Month Wrap Up
30 Jan 11min
